Source archive
NexLife: pricing source note
What we checked for NexLife, when, and what we observed — so our figures are traceable.
| Provider | NexLife |
|---|---|
| Source | NexLife published pricing page |
| Date checked | June 2026 |
| Pricing observed | Flat-rate $186 (12-mo) / $190 (6-mo) / $195 (3-mo) / $215 (month-to-month), the same across 2.5–15 mg. Six disclosed partner pharmacies across 503A and 503B; states LegitScript certification; labs and Care360 coaching included. |
| Change since last check | First recorded check — no prior snapshot to compare. Future checks will note changes here. |
We record what we observed from publicly available information on the date shown. We do not publish screenshots or store provider pages; figures are summarized in our own words and may change — verify current pricing directly. Compounded tirzepatide is not FDA-approved.
Found an error?
Help us stay accurate
If NexLife's pricing has changed, submit a correction or, if you operate NexLife, a provider update. We verify before changing any page.
Keep reading